Specialty pharma company Theratechnologies (Theratechnologies Stock Quote, Chart News TSX:TH) has be... Read More
Mixed results from the company’s latest earnings has Mackie Research Capital Corporation analyst A... Read More
Earlier this year, Endocrinology drug developer Theratechnologies (Theratechnologies Stock Quote, Ch... Read More
Following a fresh set of results from Theratechnologies (Theratechnologies Stock Quote, Chart TSX:TH... Read More
Positive new data for Theratechnologies’ (Theratechnologies Stock Quote, Chart TSX:TH) HIV tre... Read More
Echelon Wealth Partners analyst Douglas Loe says the new acquisition by drug developer Theratechnolo... Read More
Mackie Research analyst André Uddin says that the new acquisition by specialty pharma company Thera... Read More
Commenting on Theratechnologies’ (TSX:TH) second quarter financials, André Uddin of Mackie Resear... Read More
Despite first quarter results that fell below expectations, Mackie Research Capital analyst André U... Read More
Echelon Wealth Partners analyst Doug Loe is sticking to his guns on Theratechnologies (Theratechnolo... Read More
Theratechnologies (Theratechnologies Stock Quote, Chart, News: TSX:TH) third quarter results were a ... Read More
New results from Theratechnologies (Theratechnologies Stock Quote, Chart, News: TSX:TH) are further ... Read More
A better than expected quarter has Mackie Research Capital analyst André Uddin feeling good about T... Read More
His top picks for 2016, Intellipharmaceutics (Intellipharmaceutics Stock Quote, Chart, News: Nasdaq:... Read More
Results from the Phase 3 trial of Theratechnologies’ (Theratechnologies Stock Quote, Chart, Ne... Read More
Some good news on a treatment that he expects will become very important to its balance sheet has Ma... Read More
Lower than expected revenue growth for Egrifta has Echelon Wealth Partners analyst Doug Loe cutting ... Read More
Euro Pacific Canada analyst Doug Loe says he sees the potential for “strong upside” from... Read More
Share
Tweet
pin
Share